Out-of-Pocket Costs Continue to Rise for Neurologic Medications

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological diseases – epilepsy, multiple sclerosis (MS), peripheral neuropathy, Alzheimer’s disease and Parkinson’s disease. This is according to research published online in Neurology(r), the medical journal of the American Academy of Neurology. 

Read More